HCW Biologics Inc. ( HCWB) - Key Metrics
HCWB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.10 | -$11.58 | -$2.99 | -$2.99 |
| 2026Q1 | $18.71 | $11.82 | -$4.51 | -$4.51 |
| 2025Q4 | $0.08 | $2.06 | -$9.60 | -$9.60 |
| 2025Q3 | $0.04 | -$12.09 | -$8.60 | -$8.60 |
| 2025Q2 | $0.02 | -$6.50 | -$11.06 | -$11.06 |
HCWB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.11 |
| 2026Q1 | 0% | 0.05 |
| 2025Q4 | 0% | -0.15 |
| 2025Q3 | 0% | -0.46 |
| 2025Q2 | 0% | -0.15 |
HCWB
Price: $2.13
52 week price:
Earnings Per Share: -49.74 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 726
Market Capitalization: 4.3 million